Booming US crude supply should dramatically reduce the power of the oil exporters’ cartel, despite the market’s current skepticism. Read More

Hedge fund manager Dan Loeb’s billion-dollar new stake could pay off big even if the company spurns him. Read More

The retailer is betting big on its first foray outside the U.S. Here’s a look at its chances—and some of the domestic firms it’s facing off against. Read More

The best bets are the fastest-growing and most profitable producers. Their gains will pain suppliers of chemicals and biofuels Read More

Investor concerns about reporting transparency in China are overblown. Here's some perspective. Read More

The stock market continues to rise as the real economy remains stuck in neutral thanks to monetary stimulus. When the monetary music stops, large caps will drop based on "risk-off" macro beta but small caps will perform based on fundamentals. Read More

This Spanish biotech faces huge growth prospects for its leading edge treatments that could alleviate a host of intractable diseases. Read More

If we could store power as conveniently as nature does in fossil fuels, we’d be a lot richer. Here are the most promising technologies Read More

Congress is showing limited appetite for austerity and the Pentagon still wants the costliest hardware Read More

Canada's performance in the aftermath of the Great Recession was certainly impressive relative to most of the rest of the world. But it was not the product of supernatural agency. The Great White North's ability to survive and thrive was based on long-term policy choices. Read More